2,679 EMA medicines. 770+ Phase-3 trials. 82 primary sources.
FDA + EMA combined in one query. Deterministic scores. UUID-native.
One URL — your agent sees the pharma market like a regulatory expert.
Each tool call requires your api_key parameter.
Get Biotech Access →
Every tool is read-only, deterministic, and UUID-stable. FDA + EMA combined — no other free tool does this at this depth.
Six capabilities that only exist because FDA, EMA, ClinicalTrials, and news signals are all UUID-linked in one system.
Works with Claude, Cursor, Windsurf, n8n, LangChain, and any MCP-compatible framework.
// Claude.ai → Settings → Integrations → Add MCP Server { "type": "url", "url": "https://biotech.mcp.brunosan.de/mcp", "name": "brunosan-biotech" } // Or add the full intelligence stack at once: // → https://brunosan.de/intelligence/#connect
FDA approval → Finance + AI News: An FDA accelerated approval (Biotech, Phase-3 endpoint confirmed, Intel Score high) triggers Finance for M&A signals around the approved company, and AI News for decision_maker_priority_score on the drug class. Due diligence in seconds — not hours.
Competitive pipeline intelligence: get_company_pipeline("Pfizer") + get_phase3_results() → complete Phase-3 landscape for an indication. Cross-check with Finance for recent earnings signals and analyst upgrades. M&A-grade research, automated.
Pharmacovigilance daily watch: get_safety_signals() across your drug portfolio. get_eu_shortages() for supply chain risk. get_label_changes() for regulatory exposure. One briefing call — three tools — complete pharmacovigilance picture.
Every tier gives full read access to all 10 tools. Paid tiers add history depth, higher rate limits, and webhook alerts.
All payments via Mollie — secure, EU-based payment processing. Questions? access@brunosan.de
For informational purposes only — not medical or regulatory advice.